noom glp 1 companion Noom's GLP-1 Receives Major Update to Prepare for New Expected Prescription Drug Use-Related Software (PDURS) Model Noom GLP-1 Companion

Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration

Recapping the headlines that affected American's health in 2025

Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) have increasingly been used to treat type 2 diabetes mellitus

Heres what evidence says about absorption and claims, plus safety checks and questions to ask your clinician.

A new study published in April sheds light on the concerns of anesthesiologists across the United States related to the perioperative management of patients taking glucagon-like peptide-1 (GLP-1) agonists, a class of drugs now commonly prescribed for both diabetes and cosmetic weight loss

| 22 comments on LinkedIn